| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. (AUPH) has 8 insiders with recent SEC Form 4 filings, including 5 buys and 5 sells. AUPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 13.04M | $214.71M | +814.6K | |
| CEO | 1.85M | $30.37M | - | |
| COO | 695.8K | $11.45M | - | |
| CFO | 626.4K | $10.31M | - | |
| VP | 557.4K | $9.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | Leversage Jill | Director | Sale+OE | 4,815 | $11.26 | $54,216.90 | -20.6% | -15.6% | -51.1% | |
| May 19, 2023 | Hagan Joseph P | Director | Sale+OE | 272 | $10.58 | $2,877.76 | -2.2% | -10.8% | -45.9% | |
| Mar 2, 2023 | Greenleaf Peter49 | Chief Executive Officer | Sell | 32,750 | $8.94 | $292,785.00 | -3.2% | +0.2% | -35.3% | |
| Mar 2, 2023 | Miller Joseph M50 | Chief Financial Officer | Sell | 11,296 | $8.94 | $100,986.24 | -3.3% | +0.2% | -35.3% | |
| Mar 2, 2023 | Robertson Stephen P. | EVP, General Counsel | Sell | 19,402 | $8.94 | $173,453.88 | -6.0% | +0.2% | -35.3% | |
| Mar 2, 2023 | Milne George M Jr59 | Director | Buy | 20,000 | $8.91 | $178,284.00 | +40.0% | +0.2% | -35.3% | |
| Nov 21, 2022 | Donley Matthew Maxwell54 | Ex VP, Internal Operations | Buy | 10,000 | $4.66 | $46,600.00 | +55.8% | +67.7% | +88.4% | |
| Nov 9, 2022 | Habig Scott Michael46 | Chief Commercial Officer | Buy | 5,000 | $5.02 | $25,075.00 | New | +78.7% | +50.7% | |
| Nov 7, 2022 | Martin Michael Robert82 | Chief Business Officer | Buy | 30,000 | $5.16 | $154,800.00 | +50.4% | +80.2% | +64.2% | |
| Mar 9, 2022 | MacKay-Dunn R. Hector47 | Director | Buy | 5,000 | $11.00 | $54,985.00 | +83.3% | +7.9% | -16.3% |